Literature DB >> 551512

The clinical spectrum of infant botulism.

S S Arnon, J Chin.   

Abstract

Infant botulism is the systemic illness that results when spores of Clostridium botulinum germinate in the infant's intestine and then produce botulinal toxin in vivo. As with other infectious diseases, infant botulism has a spectrum of clinical severity that ranges from a mild, outpatient illness to fulminant, sudden death. Most cases reported to date have been recognized in infants so weak and hypotonic that their need for hospital care was unquestioned; yet even this group of patients displayed a wide range in severity of illness. The outpatients were initially considered to be cases of "failure to thrive," while the fulminant cases were indistinguishable at autopsy from typical instances of the sudden infant death syndrome (SIDS, crib death). This article discusses the observed spectrum of clinical severity, the management of the hospitalized patient, and the manner in which sudden death might result from production of butulinal toxin in the intestine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 551512     DOI: 10.1093/clinids/1.4.614

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  8 in total

1.  Some preliminary studies on low incidence of infant botulism in the United Kingdom.

Authors:  P R Berry; R J Gilbert; R W Oliver; A A Gibson
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 2.  Botulinum toxin. From poison to medicine.

Authors:  L E Davis
Journal:  West J Med       Date:  1993-01

3.  The pathologist and the sudden infant death syndrome.

Authors:  M Valdes-Dapena
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

4.  Infant botulism in Canada.

Authors:  D M McCurdy; C Krishnan; A H Hauschild
Journal:  Can Med Assoc J       Date:  1981-10-01       Impact factor: 8.262

Review 5.  Laboratory diagnostics of botulism.

Authors:  Miia Lindström; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 6.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

7.  Infant botulism in the United States: an epidemiologic study of cases occurring outside of California.

Authors:  J G Morris; J D Snyder; R Wilson; R A Feldman
Journal:  Am J Public Health       Date:  1983-12       Impact factor: 9.308

8.  Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test.

Authors:  P H Gilligan; L Brown; R E Berman
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.